TERT and central nervous system cancer: For TERT, it had been shown the promoter mutations were correlated with poor prognosis and shorter survival of patients with glioma [26, 27], and some researches also identified that TERT promoter mutations was an independent prognostic factor in the other human cancer [28, 29].